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ABSTRACT
Objective To examine whether pretreatment emotional
distress in women is associated with achievement of
pregnancy after a cycle of assisted reproductive
technology.
DesignMeta-analysis of prospective psychosocial
studies.
Data sources PubMed, Medline, Embase, PsycINFO,
PsychNET, ISI Web of Knowledge, and ISI Web of Science
were searched for articles published from 1985 to March
2010 (inclusive). We also undertook a hand search of
reference lists and contacted 29 authors. Eligible studies
were prospective studies reporting a test of the
association between pretreatment emotional distress
(anxiety or depression) and pregnancy in women
undergoing a single cycle of assisted reproductive
technology.
Review methods Two authors independently assessed
the studies for eligibility and quality (using criteria
adapted from the Newcastle-Ottawa quality scale) and
extracted data. Authors contributed additional data not
included in original publication.
Results Fourteen studies with 3583 infertile women
undergoing a cycle of fertility treatment were included in
the meta-analysis. The effect size used was the
standardisedmean difference (adjusted for small sample
size) in pretreatment anxiety or depression (priority on
anxiety where both measured) between women who
achieved a pregnancy (defined as a positive pregnancy
test, positive fetal heart scan, or live birth) and those who
did not. Pretreatment emotional distress was not
associated with treatment outcome after a cycle of
assisted reproductive technology (standardised mean
difference −0.04, 95% confidence interval −0.11 to 0.03
(fixed effects model); heterogeneity I²=14%, P=0.30).
Subgroup analyses according to previous experience of
assisted reproductive technology, composition of the not
pregnant group, and timing of the emotional assessment
were not significant. The effect size did not vary according
to study quality, but a significant subgroup analysis on
timing of the pregnancy test, a contour enhanced funnel
plot, and Egger’s test indicated the presence of moderate
publication bias.
Conclusions The findings of this meta-analysis should
reassure women and doctors that emotional distress
caused by fertility problems or other life events co-
occurring with treatment will not compromise the chance
of becoming pregnant.
INTRODUCTION
Infertility affects 9% to 15% of the childbearing
population,1 and 55% of those affected will seek medi-
cal advice in the hope of achieving parenthood.2Many
infertile women believe that emotional distress (for
example, tension or worry) is a contributing factor to
their lack of natural fertility and lack of success with
fertility treatment.3 These beliefs are usually based on
anecdotal evidence and oft repeated fertility myths of
spontaneous conception after holidays (“relax and
you’ll get pregnant”) or after adoption when couples
no longer have the strain of trying to conceive (“don’t
think about it and you’ll get pregnant”). In contrast,
doctors tend to consider the contribution of stress to be
negligible4 because of inconclusive results in the
empirical literature.
Assisted reproductive technologies like in vitro ferti-
lisation and intracytoplasmic sperm injection are com-
plex and stressful, and are therefore the subject of
many studies investigating emotional distress and out-
come of fertility treatment. The use of assisted repro-
ductive technologies is implicated in 1.6% of births in
Britain,5 with 35 000 women treated every year in the
United Kingdom.6 A cycle of in vitro fertilisation typi-
cally requires nine to 12 days of self injection with
potent fertility drugs to stimulate the production of
oocytes (eggs), retrieval of oocytes via transvaginal
ultrasonography, fertilisation of oocytes in the labora-
tory with partner or donor sperm, and transfer of the
resulting embryo to the uterus. Couples then wait two
to three weeks to find out whether implantation and a
pregnancy have occurred.
Patients expect assisted reproductive technologies to
be stressful,7 and 30% of couples end treatment prema-
turely because of its psychological burden.8 The con-
tribution of biological, reproductive, and lifestyle
factors to the success or failure of fertility treatment is
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well established,9 but the influence of emotional dis-
tress is inconclusive because of mixed results in psy-
chosocial studies. Emotional distress would likely
exert its effect on the chance of pregnancy by compro-
mising ovarian function10 or implantation,11 because
stress induced suppression in these phases of the repro-
ductive event is physiologically less costly than disrup-
tions at a later point in pregnancy.12
The lack of consensus in psychosocial studies exam-
ining the effect of emotional distress is likely to be
owing to heterogeneity in study designs. For example,
60% of spontaneous conceptions are lost within two
weeks of fertilisation,13 but psychosocial studies mea-
sure women at different stages of pregnancy (for exam-
ple, at two, six, or 12 weeks of pregnancy, or at
delivery) and often group together patients with differ-
ent causes of treatment failure (for example, lack of
oocytes or failure of implantation). The magnitude of
the response of the hypothalamic-pituitary-adrenal
axis to stress decreases over repeated exposures to
the same stressor,14 and so does the inhibitory effect
of stress on fertility (for example, disruption of luteinis-
ing hormone).15 However, psychosocial studies vary in
the sampling of first time versus experienced patients,
producing heterogeneity in treatment familiarity and
distress ratings. The effect of emotional distress could
be missed in some psychosocial studies because of the
long interval between emotional assessments and the
start of treatment, because stress is higher closer to the
onset of a stressful event.16 Finally, variations in other
design features (for example, length of follow-up and
statistical power) could also contribute to mixed find-
ings in this body of work.
A meta-analysis taking into account these issues
could help achieve greater certainty about the associa-
tionbetween emotional distress andpregnancy.Toour
knowledge the only previous published meta-analyses
on this topic are doctoral dissertations that produced
inconclusive results.17 18 For this reason, we conducted
a comprehensive review andmeta-analysis of prospec-
tive studies that assessed emotional distress before the
start of a fertility treatment cycle and that compared
these emotional ratings in women who subsequently
became pregnant and those who did not become preg-
nant from their cycle. We also examined whether this
association varied as a function of the aforementioned
design characteristics to examine potential causes of
inconsistency in this body of evidence.
METHODS
Identification and selection of studies
EG executed a computerised search of PubMed,Med-
line, Embase, PsycINFO, PsychNET, ISI Web of
Knowledge, and ISI Web of Science for articles pub-
lished between 1985 and March 2010 (inclusive). The
search terms were: “in vitro fertilization,” “in vitro fer-
tilisation,” “IVF,” “assisted reproduction,” “intra-
cytoplasmic sperm injection,” “ICSI,” and “assisted
reproductive techniques”; AND “psychological
stress,” “depressive disorder,” “anxiety,” “anxiety dis-
order,” “adjustment disorder,” “emotions,”
“psychosomatic medicine,” “psychological adapta-
tion,” “distress,” and “depression”. MeSH terms were
used in PubMed.We did not impose any restriction on
the type of publication (journal, conference paper, or
dissertation) or language of publication. Non-English
publicationswere reviewedwith the helpof colleagues.
Proceedings of fertility conferences were examined
where proceedings are available in computerised data-
bases (for example, European Society of Human
Reproduction and Embryology). A comprehensive
examination of the reference sections of all identified
articles was carried out. All citations were transferred
to EndNote (Thomson Reuters, San Francisco, CA).
Selection criteria, data extraction, and quality assessment
JB and EG selected the studies. The selection criteria
were that emotional distress (anxiety or depression) in
women was measured before the start of stimulation;
the outcome (pregnant or not pregnant) was reported
for a single cycle of treatment with an assisted repro-
ductive technology (in vitro fertilisation, intra-
cytoplasmic sperm injection, or gamete intrafallopian
transfer); the pregnancy outcomewas based on labora-
tory or clinical evidence; and means and standard
deviations for pretreatment emotional distress (anxiety
or depression) were available for pregnant and not
pregnant groups in the publication or through addi-
tional contact with the author.
Emotional assessment before stimulation was
required because blood tests and scans to calibrate sti-
mulation drugs can confound anxiety and depression
ratings, especially inwomenwho require a higher dose
because of poor response to treatment.7 We only
included studies that used anxiety or depression as
indicators of emotional distress because these mea-
sures are reliably related to stress induced activation
of the hypothalamic-pituitary-adrenal axis.19 Outcome
for a single cycle of treatment was used to control for
between study variation in number of cycles and dura-
tion of treatment period. Furthermore, by considering
eligible studies in which patients did not contribute
more than one treatment cycle, it was assured that the
assumption of independence of observations had not
been violated.
Duplicate or secondary publications on the same
sample (for example, Smeenk et al11 and Verhaak et
al20) were excluded from the meta-analysis to avoid
multiple publication bias. In cases where there were
multiple publications, we used the publication that
contained means and standard deviations for the lar-
gest sample from the group. Excluded studies were
classified according to reason for exclusion. JB and
EG agreed inclusion of all but one study (excluded
after discussion) and agreed on reasons for exclusion
for 98.2% of studies (details of exclusions can be
obtained from the corresponding author).
Data from each study were extracted by EG and JB,
and they agreed all entries. The following data were
extracted (where available): publication date; country;
sample size; average age and duration of infertility in
the study sample;whether the sample includedwomen
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with previous experience of assisted reproductive tech-
nologies (yes or no; if yes, the proportion of the sample
with experience); method for assessment of distress;
and definition of pregnancy for the assisted reproduc-
tive cycle. Evidence of pregnancy was classified
according to a positive pregnancy test, if based on a
β-human chorionic gonadotrophin urine or blood test
≤21 days after embryo transfer, or a positive fetal scan
if based on ultrasonographic visualisation of fetal heart
activity or live birth, as per standard definitions.21 The
composition of the “not pregnant” group in each study
was coded to indicate whether this group included all
patients that initiated a cycle and failed to get pregnant
or whether it included only those who at least reached
embryo transfer and failed to get pregnant (that is, the
latter excluded women whose cycle was cancelled
before transfer because of a poor ovarian response to
stimulation or failed fertilisation).
JB and CV assessed study quality according to the
Newcastle-Ottawa quality assessment scale,22 which
evaluates quality in terms of selection of participants,
measurement of emotional distress, comparability of
groups on confounders, and comparability of groups
on outcome and follow-up. Points were awarded if: (a)
the study sample was representative of patients using
assisted reproductive technologies (that is, more than
80% of eligible patients were invited and more than
80% agreed to participate, or sample size was more
than 300 (corresponds to 80%of average yearly patient
enrolment in most European assisted reproductive
technology clinics) (1 point)); (b) the study reliably
measured distress (that is, the study used a standard,
reliable, and valid measurement tool with respect to
its psychometric properties23 and classification of the
tool in a recent meta-analysis on psychological inter
ventions24 (1 point)); (c) the study groupswere compar-
able on confounders (that is, at study entry, subse-
quently pregnant and not pregnant groups were
comparable (not significantly different) on the prog-
nostic indicators9 of age, previous use of assisted repro-
ductive technology, parity, anddurationof infertility (2
points) or comparable on at least two of these indica-
tors (1 point)); and (d) the study had adequate outcome
and follow-up (that is, when the completion rate (num-
ber of people who agreed to participate divided by the
number analysed) for patients undergoing the cycle
was more than 80% (1 point)). The overall quality rat-
ing was the sum of met criteria (maximum five). Low,
moderate, and high quality labels were assigned to
scores of 0-2, 3, 4-5, respectively. Inter-rater agreement
for quality ratings was excellent (Cohen’s κ=0.951,
P<0.001).
Data synthesis and analysis
The primary outcome measure was the standardised
mean difference in pretreatment anxiety or depression
between the group that achieved pregnancy with the
assisted reproductive technology and the group that
did not, adjusted for small sample size usingHedges’s g
correction.25 Effect sizes were aligned across studies so
that a negative standardisedmean difference indicated
more emotional distress (depression or anxiety) in the
subsequently not pregnant group. Only one effect size
was returned per study to create an independent set of
effect sizes for emotional distress. If studies usedmulti-
ple measures, then we prioritised state anxiety because
it reflects emotional state of the moment, compared
with trait anxiety,26 and it is sensitive to anticipatory
emotional reactions (for example, tension, worry),
whereas depression is more sensitive to emotions aris-
ing from the outcome of treatment (for example, sad-
ness, feelings of loss).27 28 However, depression was
used in studies that did not measure anxiety.
A fixed effects model was adopted on the assump-
tion that study samples were drawn from the same
population and therefore estimated the same effect
size. In the presence of statistically significant hetero-
geneity, a random effects model was used. Further-
more, subgroup analyses were performed on the
basis of specific methodological and clinical character-
istics of the studies, which were defined a priori (for
example, timing of psychological assessment, opera-
tional definition of pregnancy, past use of an assisted
reproductive technology, composition of the not preg-
nant group). The inverse variance method was used to
pool the standardised mean difference. Homogeneity
of the effect size distribution was tested using the Q
statistic,29 and the I2 index was used to assess the pro-
portion of effect size variability that was owing to
non-chance factors.30 Regarding subgroup analyses,
the pooled effect sizes of each subgroupwere compared
to identify potential significant differences in the direc-
tion or magnitude of the effect. Furthermore, differ-
ences between subgroups were assessed using the χ2
test, as implemented in the ReviewManager software.
Publication bias was checked with visual inspection
of contour enhanced funnel plots31 and the Egger’s
test,32 with the slope of the regression (bias coefficient)
indicating the extent of any bias. Publication bias was
further assessed by application of the trim and fill
method. Trim and fill is an iterative non-parametric
method used to investigate the number of ‘‘missing’’
studies in a meta-analysis, as indicated by funnel plot
asymmetry, and calculates an adjusted pooled estimate
with the addition of those “missing” studies.33 The
probability level of P<0.05 was used to indicate statis-
tical significance.
We used ReviewManager version 5.0.24 (Nordic
Cochrane Centre, Copenhagen, Denmark) to calcu-
late all effect sizes, and for the meta-analysis and forest
plots. Stata (StataCorp, College Station, TX) was used
Studies identified 1985 to March 2010 (n=1175)
Studies included (n=14)
Excluded (n=1161):
  By title (n=972)
  By abstract (n=152)
  By text (n=37)
Fig 1 | Decision flowchart for identified studies
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for the Egger’s test, the trim and fill method, and the
construction of the contour enhanced funnel plot.
RESULTS
Description of studies
The database and manual search yielded 1175 non-
duplicated records that contained the relevant psycho-
logical and reproductive search terms, but 1161
(98.8%) did not meet inclusion criteria and were
excluded (fig 1). The main reasons for exclusion were
that the studywasnot relevant (597, 50.8%), didnot test
the relationship between distress and pregnancy (215,
18.3%), or did not contain primary quantitative data
(186, 15.8%). We contacted 29 authors to obtain
unpublished work (including unpublished disserta-
tions) and additional data, which was successful in all
but three cases.
Table 1 shows that the 14 included studies sampled
3583 women in 10 countries. The range across studies
for average age was 29.7 to 36.8 years and for duration
of infertility 2.6 to 7.8 years. Three studies sampled
patients that had never used an assisted reproductive
technology, and 11 studies included amixed sample of
patients with and without past use of an assisted repro-
ductive technology. Table 2 shows the design features
of the studies. The data collection period across studies
was from 1992 to 2006 (four studies did not report the
data collection period). The most commonly used
measure of emotional distress was the Spielberger
state-trait anxiety inventory, which is a reliable and
validated measure of state anxiety. 23 24 Distress was
most frequently assessed within a month of the treat-
ment cycle (6/14 studies; three did not specify). Preg-
nancy was operationally defined as a positive fetal
heart scan (clinical pregnancy) in eight studies, positive
pregnancy test in four studies (preclinical pregnancy),
and a live birth in two studies. In six of the 14 studies,
all womenwho initiated the cycle but failed to get preg-
nant were included in the not pregnant group, whereas
in eight studies only women who at least underwent
embryo transfer were included.
Table 3 shows themodifiedNewcastle-Ottawa qual-
ity ratings for each study (for full details on each quality
indicator see the supplemental web table on bmj.com).
Participant selection in seven studies met the criteria
for having a truly or somewhat representative sample,
with the remaining studies using non-consecutive
recruitment (that is, doctor referral to study734-36 or a
selected patient group37-40). The reliability quality cri-
terion was met in 13studies, which all used a recog-
nised reliable and valid measure of emotional
distress. Three studies showed comparability of groups
at study entry on all four key confounders of age, pre-
vious use of assisted reproductive technology, parity,
and duration of infertility. Follow-up showed comple-
tion rates above 80% for 11 studies (after exclusion of
participants who did not start the cycle because of
becoming pregnant on the waiting list or deciding
against using assisted reproductive technologies).
Twelve studies were published in a peer reviewed jour-
nal and two in conference abstracts. 37 41 Total quality
ratings indicated five low quality studies, three average
studies, and six high quality studies.
Meta-analysis
Figure 2 shows the pooled standardised mean differ-
ences in pretreatment emotional distress between the
subsequently pregnant andnot pregnant groups for the
fixed effects model. The meta-analysis showed a
non-significant overall effect size of distress on the like-
lihood of pregnancy (−0.04, 95% CI −0.11 to 0.03),
with non-significant heterogeneity between studies
(I²=14%, P=0.30). Sensitivity analysis using a random
effects model produced similar results, with a pooled
effect size of −0.05 (95% CI −0.14 to 0.03).
Subgroup analyses
Regarding the subgroup analyses, no statistically sig-
nificant differences were observed between subgroups
Table 1 | Sample characteristics reported in the 14 included studies
Country
Women who got
pregnant (n)
Womenwhodidnot
get pregnant (n)
Age of women
(years; mean (SD))
Duration of infertility
(years; mean (SD))
Previously used assisted reproductive
technologies (yes/no (%))
Akyuz et al 200637* Turkey 39 41 — — Yes (60%)
Anderheim et al 200547 Sweden 58 81 32.1 (3.6) 4.5 (2.4) Yes (7.24%)
Boivin and Takefman 19957 Canada 17 23 33.3 (3.6) 4.4 (2.1) No
de Klerk et al 200840 Netherlands 73 216 32.8 (3.1) 3.6 (1.9) Yes (6%)†
Demyttenaere et al 199236 Belgium 10 30 32.4 (4.1) 5.6 (2.6) Yes (57.50%)
Demyttenaere et al 199835 Belgium 23 75 29.7 (3.5) 4.1 (3.1) Yes (43.88%)
Ebbesen et al 200948 Denmark 215 566 31.2 (3.9) 2.6 (1.9) No
Klonoff-Cohen et al 200139 USA 46 90 36.8 (4.3) 4.1 (3.0) Yes (37%)
Lancastle and Boivin 200510 UK 13 63 33.3 (3.3) 7.8 (3.0) Yes (35.05%)
Lee et al 200641 USA 364 440 — 3.2 (2.4) Yes (-)
Lintsen et al 200949 Netherlands 196 494 33.2 (3.5) 3.4 (1.8) No
Merari et al 200238 Israel 23 90 33.9 (5.3) 7.2 (4.9) Yes (-)
Sanders and Bruce 199934 Australia 15 75 32.6 (4.4) — Yes (23.30%)
Verhaak et al 200120 Netherlands 59 148 33.4 (3.7) 3.7 (2.0) Yes (12.5%)
*51.2% were 31-35 years of age, and duration of infertility was 2-7 years for 61%.
†All participants with previous use of an assisted reproductive technology had had a live birth.
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for timing of the emotional assessment (P=0.66), pre-
vious use of assisted reproductive technology (P=0.66),
and composition of the not pregnant group (P=0.39).
Specifically, the effect size for studies that undertook
emotional assessment within one month of the treat-
ment cycle (n=6; standardised mean difference −0.01,
95% CI −0.12 to 0.10; heterogeneity I²=37%, P=0.16)
was similar to that for studies that did emotional assess-
ment more than one month before treatment (n=5;
−0.05, 95% CI −0.18 to 0.08; I²=0%, P=0.55). Three
studies did not specify precisely when emotional
assessment took place.35-37 The effect size was compar-
able for studies that included first time users of assisted
reproductive technologies (n=3; −0.02, 95% CI −0.13
to 0.09; I²=0%, P=0.59) and studies that had a mixed
sample of repeat and first time patients (n=11; −0.05,
95% CI −0.15 to 0.04; I²=28%, P=0.18). The studies
that included only not pregnant women who had
undergone embryo transfer had a greater, although
not significantly so, effect size (n=8; −0.06, 95% CI
−0.16 to 0.03; I²=0%, P=0.43) than studies that
included all initiated patients who did not become
pregnant (n=6; −0.00, 95% CI −0.11 to 0.11; I²=33%,
P=0.19). The subgroup analysis according to definition
of pregnancy detected a significant difference between
the two subgroups (P=0.006). Studies that used a posi-
tive pregnancy test to define a pregnancy had a signifi-
cant pooled standardisedmean difference that showed
more distress in subsequently not pregnant women
than in those who did get pregnant (n=4; −0.42, 95%
CI −0.71 to −0.14; I²=0%, P=0.97), whereas no differ-
ence between groups was detected in studies that
defined pregnancy as a positive fetal scan or live birth
(n=10; −0.01, 95% CI −0.09 to 0.06; I²=0%, P=0.59).
Study quality and publication bias
We performed a subgroup analysis according to study
quality (that is, low, average, or high), and this analysis
was not significant (P=0.79). Effect size was similar for
the low quality category (n=5; standardised mean dif-
ference −0.04, 95% CI −0.16 to 0.08; heterogeneity
I²=42%, P=0.14), average quality category (n=3;
−0.10, 95% CI −0.30 to 0.10; I²=22%, P=0.28), and
high quality category (n=6; −0.02, 95% CI −0.12 to
0.08; I²=3%, P=0.40). The contour enhanced funnel
plot (fig 3) showed evidence of asymmetry. The oval
red area, where “missing” studieswould be expected in
order to correct for the visually detected asymmetry,
lies within the non-significant regions of the plot; thus
publication bias could be suspected as themain reason
for the observed asymmetry. 31 This notion was con-
firmed with a significant Egger’s test, which indicated
the presence of moderate publication bias (−1.31, 95%
CI−2.36 to−0.27; P=0.018). Furthermore, the addition
of four “missing” studies imputed using the trim and fill
method (white circles in fig 3) reduced the magnitude
Table 2 | Characteristics of the design of the 14 included studies
Data collection
period Population Measure of emotional distress
Timing of assessment
for emotional distress
Operational
definition of
pregnancy*
Composition of
not pregnant
group†
Akyuz et al 200637 2004 to 2005 Unexplained, only
intracytoplasmic sperm injection
Spielberger state-trait anxiety
inventory
Beginning of cycle Positive test With transfer
Anderheim et al 200547 1999 to 2002 Consecutive patients Psychological general wellbeing:
anxiety subscale
1monthbefore treatment Positive scan With transfer
Boivin and Takefman
19957
1992 to 1994 Referred by doctor, first time users Spielberger state-trait anxiety
inventory
>1.8 months before
treatment
Positive test With transfer
de Klerk et al 200840 2002 to 2004 Consecutive patients, single
embryo transfer
Hospital anxiety and depression
scale: anxiety subscale
6weeksbefore treatment Live birth With transfer
Demyttenaereetal199236 Not reported Consecutive patients Zung depression inventory Day 4 to 5 of cycle Positive test All
Demyttenaereetal199835 Not reported Referred by doctor, primary
infertility
Zung depression inventory Day 3 of cycle Positive scan All
Ebbesen et al 200948 2001 to 2006 Consecutive patients, first time
users
Beck depression inventory II Before first scan Positive scan With transfer
Klonoff-Cohenetal200139 1993 to 1998 Patients Profile of moods scale (unipolar):
anxiety
Before first visit Live birth With transfer
Lancastle and Boivin
200510
1995 to 1997 Consecutive patients Spielberger state-trait anxiety
inventory
2.8 months before
treatment
Positive test With transfer
Lee et al 200641 Not reported Patients Center for Epidemiologic Studies
depression scale
Day 3 of cycle Positive scan All
Lintsen et al 200949 2002 to 2004 Consecutive patients, first time
users
Spielberger state-trait anxiety
inventory
1 to 2 months before
treatment
Positive scan With transfer
Merari et al 200238 Not reported Consecutive, unexplained
infertility/tubal, primary infertility
Spielberger state-trait anxiety
inventory
10 to 15 days before
treatment
Positive scan All
SandersandBruce199934 1990 to 1993 New patients Spielberger state-trait anxiety
inventory
1 to 3 months before
treatment
Positive scan All
Verhaak et al 200120 1999 Consecutive patients Spielberger state-trait anxiety
inventory
3 to 10 days before
treatment
Positive scan All
*Positive test=positive pregnancy test; positive scan=positive fetal ultrasound scan.
†Composition of the not pregnant group refers to whether the not pregnant group included all patients initiating the cycle (All) or only patients that at least had an embryo transfer (With
transfer).
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of the pooled effect size and shifted it closer to zero
(adjusted standardised mean difference −0.01, 95%
CI −0.08 to 0.06).
DISCUSSION
Principal findings
After many decades of research investigating the asso-
ciation between pretreatment emotional distress and
the outcome of fertility treatment, this meta-analysis
of 14 prospective studies supports the view that emo-
tional distress (for example, feelings of tension, ner-
vousness, or worry) is unlikely to be a cause of failure
of fertility treatment.4 These findings should reassure
women that emotional distress caused by fertility pro-
blems or other life events co-occurring with treatment
will not compromise their chance of becoming preg-
nant. Despite these encouraging results, however, defi-
nitive research on this psychobiological link is lacking.
The hypothalamic-pituitary-gonadotrophin axis has
evolved into a precise system with numerous mechan-
isms to guard against suboptimal reproductive condi-
tions, including activation of the axis that organises the
stress response (the hypothalamic-pituitary-adrenal
axis). The fact that total fertility rates are often highest
in countries that experience the harsh conditions of
war, poverty, and famine42 support such a contention.
However, evolutionary theory could account for this
paradox,43 and there is compelling experimental evi-
dence in non-human animals44 that these checks do not
always work.
Strengths and limitations
Ameta-analysis of this literaturewas timely and appro-
priate given that the studies available had low power
but generally satisfactory designs, methods, and out-
comes. One of the strengths of this review is the
comprehensive search strategy that identified a large
number of studies from 10 countries. The 14 included
studies were generally of average to high quality, with
themainmethodological weaknesses being use of con-
venience samples (that is, non-consecutive or selected
samples), failure to fully demonstrate the equivalence
of the pregnant and not pregnant groups on prognostic
indicators before treatment although partial evidence
was provided in most included studies), and low
power. All included studies measured distress before
the start of stimulation, and all assessed outcome after
a single cycle of treatment with assisted reproductive
technology, precluding the effect of confounding pro-
cedural stress7 and the effect of variability in the num-
ber of assisted reproductive cycles.
The quality of themeasurements in the included stu-
dies was generally high because well validated and
standardised instruments of emotional distress and
laboratory or clinical indices of pregnancy were used
(except live births). The source studies were published
in peer reviewed journals (except for two abstracts).
The meta-analysis results showed low heterogeneity
between studies (overall I2 index 14%), whereas the
presence of moderate publication bias did not seem
to markedly influence the direction or the significance
of the observed effect.
This meta-analysis cannot exclude the possibility
that psychobiological associations between stress and
fertility could be captured using other designs and
populations. Assisted reproductive technologies like
in vitro fertilisation require multiple external inter-
ventions (for example, stimulation with powerful ferti-
lity drugs and luteal support during implantation), and
the level of emotional distress reported by most
patients28 may not be sufficient to disrupt a reproduc-
tive event supported in this way. Effects (if they exist)
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Fig 2 | Means and standard deviations for pretreatment emotional distress in subsequently pregnant and not pregnant women
and forest plot of the standardised mean difference in pretreatment emotional distress between groups
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may bemore apparent in untreated (orminimally trea-
ted) populations trying to conceive. Indeed, experi-
mental evidence of stress induced reproductive
suppression is found only in studies of untreated
animals.44
The main analytic approach in the included studies
was to compare the pretreatment level of distress in sub-
sequently pregnant and not pregnant groups. This
approach could have been problematic because the
overall prevalence of high anxiety is low even in an
infertile population (about 15%28), and the prevalence
of levels of anxiety capable of disrupting fertility is prob-
ably even lower. Averaging emotional distress within
outcome groups could therefore dilute associations
because of the predominance of low anxiety partici-
pants. An alternative strategy would be to use longitu-
dinal designs and multivariate models (for example,
logistic regression) that are capableofprospectively test-
ing whether emotional distress predicts treatment out-
come while controlling for potential confounders. It
would be imperative for such research to clearly specify
the number of treatment cycles, the period of follow-up,
or both to allow studies to be compared.
Stress effects may also be more easily detected in
specific stages of pregnancy, and there was evidence
suggestive of this possibility in our results. The four
included studies that defined pregnancy according to
a positive pregnancy test during the early implantation
stage, when natural conceptions are most likely to
fail,13 had larger effect sizes than studies that assessed
outcome at later stages of pregnancy (that is, by fetal
scan or live birth). However, owing to the lack of a
plausible theory to account for a stress effect at implan-
tation that is not followed through to later pregnancy,
and the fact that these four studies were the smallest of
those included in this meta-analysis, small study bias
should be considered the most likely cause of the posi-
tive associations observed.
Finally,multiple cycles of assisted reproductive tech-
nologies are often required to achieve a pregnancy,
and stress effects may become more pronounced after
repeated treatments. Our subgroup analysis according
to previous treatment experience, and other research
on the adaptation of the hypothalamic-pituitary-adre-
nal axis to stress,14 15 suggest that stress is unlikely to
affect the chances of achieving pregnancy in a subse-
quent cycle. However, emotional distress may reduce
the overall chance of success by making couples less
Effect estimate
S
ta
nd
ar
d 
er
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r
-1.0 -0.5 0 0.5 1.0
0.4
0.3
0.2
0.1
0 Studies
0.1 > P > 0.05
0.05 > P > 0.01
P < 0.01
Fig 3 | Contour enhanced funnel plot for meta-analysis of the
association between pretreatment emotional distress and
achievement of pregnancy in women undergoing a cycle of
fertility treatment with an assisted reproductive technology.
The red eclipse represents the area where four studies (white
circles) were imputed when the trim and fill method was
applied
Table 3 | Quality ratings for the 14 included studies on the basis of an adapted Newcastle-Ottawa quality assessment scale22
Quality criterion
Overall quality
rating¶Representative*
Reliably measured
distress†
Comparable on
confounders‡
Adequate outcome
and follow-up§
Akyuz et al 200637 0 1 0 1 Low
Anderheim et al 200547 1 0 0 1 Low
Boivin and Takefman 19957 0 1 2 1 High
de Klerk et al 200840 1 1 1 0 Average
Demyttenaere et al 199236 0 1 Not reported 1 Low
Demyttenaere et al 199835 0 1 2 1 High
Ebbesen et al 200948 1 1 1 1 High
Klonoff-Cohen et al 200139 0 1 1 1 Average
Lancastle and Boivin 200510 1 1 1 0 Average
Lee et al 200641 1 1 0 Not reported Low
Lintsen et al 200949 1 1 1 1 High
Merari et al 200238 0 1 2 1 High
Sanders and Bruce 199934 0 1 Not reported 1 Low
Verhaak et al 200120 1 1 1 1 High
*The representativeness criterion was met when ≥80% of women eligible were invited and 80% agreed to participate, or when sample size >300 (1
point).
†The reliability criterion was met when reliable and valid methods were used to assess anxiety or depression (1 point).
‡The comparability criterion was met when studies showed evidence that at study entry the pregnant and not pregnant groups were equivalent on the
prognostic indicators of age, previous use of assisted reproductive technology, parity, and duration of infertility (2 points) or comparable on at least
two of these indicators (1 point)
§The quality of outcome and follow-up criterion was met when the completion rate (agreed to participate/analysed) for patients undergoing the cycle
was ≥80% (1 point).
¶The overall quality rating was low (0 to 2 points), average (3 points), or high (4 or 5 points).
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willing to stay in treatment for the optimal number of
cycles,8 and further research is needed to investigate
this possibility.
Conclusions and future research
Overall this meta-analysis indicates a lack of associa-
tion between pretreatment emotional distress and
pregnancy outcome in women undergoing a cycle of
treatment with an assisted reproductive technology.
This finding provides doctors with the evidence to
reassure women that feelings of tension, worry, or
depression experienced as a result of their fertility pro-
blem, its treatment, or other co-occurring life events
are unlikely to further reduce chances of pregnancy.
Examining the association between emotional distress
and treatment outcome in other populations (for exam-
ple, untreated populations, or women who receive less
invasive treatment ormultiple cycles), at different time
points in pregnancy, using other outcomes (treatment
discontinuation), or using a more suitable analytic
approach could widen the applicability of this finding.
Despite the reassurance women can be given about
the effects of stress on the likelihood of pregnancy
when using assisted reproductive technologies, there
is abundant evidence of subclinical and clinical levels
of anxiety and depression among infertile women
about to undergo these treatments.28 As such, patients
may still want interventions to improve quality of life
during treatment. Interventions that enhance patient-
physician communication45 or that help patients to
cope with the two week waiting period before their
pregnancy test46 target aspects of treatment known to
be particularly demanding and could help maintain
quality of life during treatment.
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